Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for ...

Routine liver function tests (LFTs) typically comprise alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), ...

Like many countries in recent years, Kenya has been facing its first mpox epidemic. Clotilde Bigot reports from Mombasa.

FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...

Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with ...

The Texas A&M Board of Regents named Kiril Dimitrov, DVM, Ph.D., director of the Texas A&M Veterinary Medical Diagnostic ...

Novartis' GanLum met key Phase 3 goals, showing strong efficacy and safety in malaria patients, including against resistant ...

Here's an analysis of the annual report of DHANLAXMI BANK for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of DHANLAXMI BANK. Also includes updates on the ...

Novartis phase III trial for next-generation malaria treatment KLU156 meets primary endpoint, with potential to combat antimalarial resistance: Basel Friday, November 14, 2025, 09 ...